Akebia Therapeutics, Inc. AKBA
- Vafseo — Anemia Due to Chronic Kidney Disease Approved
- AKB-9090 — Cardiac Surgery-Related Acute Kidney Injury Phase 1
- AKB-9090 — Acute Respiratory Distress Syndrome Preclinical
- AKB-10108 — Retinopathy of Prematurity Preclinical